Gene: ATP5PB
Official Full Name: ATP synthase peripheral stalk-membrane subunit bprovided by HGNC
Gene Summary: This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the b subunit of the proton channel. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19578 | ATP5PB Knockout cell line (HeLa) | Human | ATP5PB | 1:3~1:6 | Negative | Online Inquiry |
KO19579 | ATP5PB Knockout cell line (HCT 116) | Human | ATP5PB | 1:2~1:4 | Negative | Online Inquiry |
KO19580 | ATP5PB Knockout cell line (HEK293) | Human | ATP5PB | 1:3~1:6 | Negative | Online Inquiry |
KO19581 | ATP5PB Knockout cell line (A549) | Human | ATP5PB | 1:3~1:4 | Negative | Online Inquiry |
ATP5PB Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate the study of the ATP5PB gene, which encodes a critical protein component of the mitochondrial ATP synthase complex. This gene plays a crucial role in ATP production and energy metabolism within cells. By creating knockout cell lines, researchers can investigate the consequences of ATP5PB gene disruption on cellular respiration, energy homeostasis, and metabolic processes, enabling a deeper understanding of mitochondrial function and its implications in various pathologies.
The primary function of these knockout cell lines is to provide a robust platform for examining the physiological and biochemical alterations stemming from the absence of the ATP5PB gene. By leveraging CRISPR-Cas9 technology, the knockout cell lines exhibit a complete loss of ATP5PB expression, allowing researchers to elucidate its role in energy production, oxidative stress, and apoptosis. These models also facilitate screening for therapeutic strategies targeting mitochondrial dysfunction linked to diseases such as cancer, neurodegeneration, and metabolic disorders.
The scientific importance of ATP5PB gene knockout cell lines is underscored by their applicability in both research and clinical settings. They serve as invaluable tools for drug discovery and the evaluation of novel therapeutic agents aimed at restoring mitochondrial function. Moreover, the insights gained from studies utilizing these cell lines can contribute to the foundational understanding of mitochondrial disorders, further emphasizing the need for targeted research in this field.
Compared to other models, ATP5PB gene knockout cell lines offer unique advantages such as high specificity and reproducibility of results. This precise manipulation of the ATP5PB gene results in cell lines that are representative of human pathogenic conditions, thus enhancing the translational potential of research findings. Furthermore, these cell lines are readily accessible and compatible with various laboratory techniques, from metabolic assays to high-throughput screening.
Researchers and clinicians seeking to unravel the complexities of mitochondrial biology will find value in ATP5PB gene knockout cell lines, as they provide an essential framework for advancing our understanding of cellular energy dynamics. Our company is committed to delivering high-quality biological products, and our expertise in genetic engineering ensures that our ATP5PB knockout cell lines are meticulously developed for reliability and effectiveness in scientific investigations. With these resources, we aim to support groundbreaking research that drives innovation in the field of mitochondrial health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.